Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

Cultured mononuclear peripheral blood leukocytes (PBL) from nonimmune human beings and monkeys are nonpermissive to dengue 2 virus (D2V) infection at multiplicities of infection of 0.001-0.1, but become permissive when non-neutralizing dengue antibody is added to medium. D2V infection occurred in PBL prepared from anti-coagulated but not from defibrinated plasma. Infection enhancement was produced by multiple lots of heterotypic anti-dengue raised in several mammalian species. Homotypic anti-dengue neutralized D2V at high concentrations but enhanced at low concentrations; enhancement end point in one serum was 1:320,000. The infection-enhancing factor was a noncytophilic antibody of the IgG class. D2V infection occurred in the absence of heat-labile complement components but did not occur when complexes were prepared with anti- dengue F(ab)(2). Treatment of PBL with several proteases increased permissiveness to D2V infection by immune complexes but not by virus alone. Two rhesus monkey serums collected 14 days after D2V infection contained an IgG antibody with high-titered enhancing activity but with no hemagglutination-inhibition or neutralizing activity. Virus-antibody complexes are irreversibly attached to PBL within 15 min and completely internalized in 60 min. There was considerable variation in cellular infection in different experiments, however, maximum virus yields usually exceeded 1,000 plaque-forming units per 1 x 10(6) PBL occurring between 2 and 4 days in culture. In vitro antibody-dependent infection of PBL provides a possible model for study of pathogenetic mechanisms in infants with dengue shock syndrome who passively acquire maternal anti-dengue IgG.

[1]  A. Allison,et al.  Ability of activated complement components to induce lysosomal enzyme release from macrophages , 1976, Nature.

[2]  P. Ward,et al.  LEUKOTACTIC FACTORS ELABORATED BY VIRUS-INFECTED TISSUES , 1972, The Journal of experimental medicine.

[3]  A. Böyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[4]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .

[5]  A. Nisalak,et al.  Recurrence of epidemic dengue hemorrhagic fever in an insular setting. , 1969, The American journal of tropical medicine and hygiene.

[6]  W. Bancroft,et al.  Shock syndrome in primary dengue infections. , 1976, The American journal of tropical medicine and hygiene.

[7]  S. Halstead Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. , 1970, The Yale journal of biology and medicine.

[8]  S. Halstead,et al.  Observations related to pathogenesis of dengue hemorrhagic fever. 3. Virologic studies of fatal disease. , 1970, The Yale journal of biology and medicine.

[9]  A. Sartorelli,et al.  Use of sarcoma 180/TG to prepare hyperimmune ascitic fluid in the mouse. , 1966, Journal of immunology.

[10]  S. Halstead,et al.  Antibody response in dengue and dengue hemorrhagic fever. , 1967, Japanese journal of medical science & biology.

[11]  A. Allison,et al.  Effects of activated complement components on enzyme secretion by macrophages. , 1976, Immunology.

[12]  J. Fahey,et al.  Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity. , 1974, Journal of immunology.

[13]  T. Burke Dengue haemorrhagic fever: a pathological study. , 1968, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  B. Vernon‐roberts The effects of steroid hormones on macrophage activity. , 1969, International review of cytology.

[15]  S. Halstead,et al.  Dengue Virus Replication Enhancement in Peripheral Blood Leukocytes from Immune Human Beings 1 , 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[16]  S. Cohen,et al.  Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. , 1969 .

[17]  S. Halstead,et al.  Dengue and Chikungunya Virus Infection in Man in Thailand, 1962–1964 , 1969 .

[18]  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. , 1958, The American journal of tropical medicine and hygiene.

[19]  S. Halstead,et al.  Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. , 1973, The Journal of infectious diseases.

[20]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[21]  I. Maclennan,et al.  The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes. , 1970, Immunology.

[22]  S. Halstead,et al.  Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. , 1973, The Journal of infectious diseases.

[23]  S. Halstead,et al.  Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host. , 1970, The Yale journal of biology and medicine.

[24]  S. Halstead,et al.  Antibody-enhanced dengue virus infection in primate leukocytes , 1977, Nature.

[25]  D. Bitter‐Suermann,et al.  Interaction of C3b, B, and D in the alternative pathway of complement activation. , 1975, Journal of immunology.

[26]  A. Allison,et al.  Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection , 1977, The Journal of experimental medicine.

[27]  S. Halstead Mosquito-borne haemorrhagic fevers of South and South-East Asia. , 1966, Bulletin of the World Health Organization.

[28]  J. S. Porterfield,et al.  A simple micro-culture method for the study of group B arboviruses. , 1969, Bulletin of the World Health Organization.

[29]  A. Nisonoff,et al.  Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds. , 1960, Archives of biochemistry and biophysics.

[30]  S. Halstead,et al.  Immunological enhancement of dengue virus replication. , 1973, Nature: New biology.

[31]  Pathogenetic mechanisms in dengue haemorrhagic fever: report of an international collaborative study. , 1973, Bulletin of the World Health Organization.

[32]  A. Sabin Research on dengue during World War II. , 1952, The American journal of tropical medicine and hygiene.

[33]  R. Snyderman,et al.  Inflammation and Herpes Simplex Virus: Release of a Chemotaxis-Generating Factor from Infected Cells , 1970, Science.

[34]  S. Cohen,et al.  Shock associated with dengue infection. I. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand, 1964. , 1966, The Journal of pediatrics.

[35]  A. Nisalak,et al.  A plaque reduction test for dengue virus neutralizing antibodies. , 1967, Journal of immunology.

[36]  H. Müller-Eberhard,et al.  The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. , 1973, The New England journal of medicine.